ArticleAnnals of clinical microbiology and antimicrobials2025

Activity of imipenem/relebactam against KPC-producing Klebsiella pneumoniae and the possible role of Ompk36 mutation in determining resistance: an Italian retrospective analysis.

Emanuele Palomba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.